biosig_rgb.png
BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
July 20, 2023 07:11 ET | BioSig Technologies, Inc.
Westport, CT, July 20, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
biosig_rgb.png
BioSig Joins Webull Corporate Connect
June 29, 2023 08:30 ET | BioSig Technologies, Inc.
Westport, CT, June 29, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
biosig_rgb.png
BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare
June 27, 2023 08:30 ET | BioSig Technologies, Inc.
Westport, CT, June 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
FBI LOGO TM.png
Foot Orthotic Insoles Market Size to Surpass USD 6.26 Billion in 2030, exhibiting a CAGR of 6.8%
June 22, 2023 07:34 ET | Fortune Business Insights
Pune, India, June 22, 2023 (GLOBE NEWSWIRE) -- The global foot orthotic insoles market size was USD 3.62 billion in 2022. The market is anticipated to expand from USD 3.96 billion in 2023 to USD...
CytoSorbents New Logo - 2021.png
CytoSorbents Announces Independent Data Safety and Monitoring Board Recommends Completion of the Pivotal STAR-T Trial Without Modifications Following Second Scheduled Safety Review
June 15, 2023 07:00 ET | CytoSorbents
PRINCETON, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
biosig_rgb.png
BioSig to Highlight New Data from the PURE EP™ Platform at Heart Rhythm 2023
May 03, 2023 09:00 ET | BioSig Technologies, Inc.
Westport, CT, May 03, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
CytoSorbents New Logo - 2021.png
CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
April 20, 2023 07:00 ET | CytoSorbents
PRINCETON, N.J., April 20, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
biosig_rgb.png
BioSig Announces New Advisory Board Member Edwin Wang
March 27, 2023 08:38 ET | BioSig Technologies, Inc.
Westport, CT, March 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig Announces New Advisory Board Member Lorraine Spurge
March 24, 2023 08:30 ET | BioSig Technologies, Inc.
Westport, CT, March 24, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig Confirms No Exposure to Silicon Valley Bank
March 13, 2023 07:30 ET | BioSig Technologies, Inc.
Westport, CT, March 13, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...